Boonjaraspinyo, Sirintip <br/><br/>
Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma.  [electronic resource] 

 -  Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine  Oct 2012 
 - 1785-802 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1423-0380 
<br/><br/><label>Standard No.: </label>10.1007/s13277-012-0438-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Base Sequence<br/>Bile Duct Neoplasms--diagnosis<br/>Bile Ducts, Intrahepatic--pathology<br/>Biomarkers, Tumor--analysis<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Cholangiocarcinoma--diagnosis<br/>Female<br/>Humans<br/>Indoles--pharmacology<br/>Male<br/>Middle Aged<br/>Mutation<br/>Neoplasm Staging<br/>Opisthorchiasis--complications<br/>Platelet-Derived Growth Factor--analysis<br/>Prognosis<br/>Pyrroles--pharmacology<br/>Receptor, Platelet-Derived Growth Factor alpha--antagonists & inhibitors<br/>Sunitinib